학술논문
GEM2017FIT Trial: Induction Therapy with Bortezomib-Melphalan and Prednisone (VMP) Followed By Lenalidomide and Dexamethasone (Rd) Versus Carfilzomib, Lenalidomide and Dexamethasone (KRd) Plus/Minus Daratumumab (D), 18 Cycles, Followed By Consolidation and Maintenance Therapy with Lenalidomide and Daratumumab: Phase III, Multicenter, Randomized Trial for Elderly Fit Newly Diagnosed Multiple Myeloma (NDMM) Patients Aged between 65 and 80 Years
Document Type
Journal
Author
Mateos, Maria-Victoria; Paiva, Bruno; Cedena Romero, Maria Teresa; Puig, Noemi; Sureda Balari, Anna Maria; Oriol, Albert; Ocio, Enrique M.; Rosinol, Laura; Gonzalez-Montes, Yolanda; Jose Bargay, Juan; Gonzalez Garcia, Esther; Hernandez Garcia, Miguel Teodoro; Ramirez, Angel; Suarez-Cabrera, Alexia; Blanchard, Maria-Jesus; Garzon, Sebastian; Casado Montero, Luis Felipe; Cabanas Perianes, Valentin; Perez De Oteyza, Jaime; Gironella, Mercedes; Martinez-Lopez, Joaquin; Ana-Isabel-Teruel; Delgado, Pilar; Prieto, Elena; Lahuerta Palacios, Juan Jose; Blade, Joan; San Miguel, Jesus
Source
Subject
Language
English
ISSN
15280020